Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration.

Authors:
Kim J; Kim JS; Kim D; Bello AB; Kim BJ and 2 more

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10629

PMCID:
PMC10905541

PMID:
38435815

Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1: supporting information acknowledgments we would like to express our gratitude to the korea national institute of health (knih) for providing us with two human ipsc lines (hfsips1 and cmc-hipscs-022)."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no competing interests."

Evidence found in paper:

"FUNDING INFORMATION This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF‐2019M3A9H1032376, 2022R1A2C3004850 and RS‐2023‐00208529). Additionally, this study was supported by the 2023 Research Grant from Kangwon National University (202304810001)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025